Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like Politically Connected Patrick Soon-Shiong Questioned Over Genetic Tests November 5, 2017 BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC February 14, 2017 FDA Grants Orphan Drug Designation for Retrotope's RT001 in the Treatment of Phospholipase 2G6 (P… November 1, 2017
BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC February 14, 2017
FDA Grants Orphan Drug Designation for Retrotope's RT001 in the Treatment of Phospholipase 2G6 (P… November 1, 2017
